HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 83 filers reported holding HARVARD BIOSCIENCE INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $377,390 | +88.6% | 87,765 | +140.8% | 0.03% | +82.4% |
| Q2 2023 | $200,105 | +132.7% | 36,449 | +198.4% | 0.02% | +240.0% |
| Q4 2021 | $86,000 | -80.3% | 12,216 | -80.5% | 0.01% | -79.2% |
| Q3 2021 | $437,000 | -24.4% | 62,657 | -9.7% | 0.02% | -22.6% |
| Q2 2021 | $578,000 | +51.3% | 69,420 | -0.9% | 0.03% | +40.9% |
| Q1 2021 | $382,000 | +29.5% | 70,038 | +1.9% | 0.02% | +4.8% |
| Q4 2020 | $295,000 | -3.9% | 68,710 | -32.6% | 0.02% | +110.0% |
| Q3 2020 | $307,000 | -24.6% | 101,936 | -22.4% | 0.01% | -9.1% |
| Q2 2020 | $407,000 | +324.0% | 131,418 | +202.3% | 0.01% | +266.7% |
| Q1 2020 | $96,000 | -33.8% | 43,475 | -8.3% | 0.00% | +50.0% |
| Q4 2019 | $145,000 | +1.4% | 47,434 | +2.3% | 0.00% | 0.0% |
| Q3 2019 | $143,000 | – | 46,380 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AMH Equity Ltd | 2,053,907 | $8,626,409 | 9.88% |
| B. Riley Asset Management, LLC | 3,408,796 | $14,316,943 | 5.93% |
| Meros Investment Management, LP | 1,124,206 | $4,721,665 | 2.69% |
| Harvey Partners, LLC | 2,712,700 | $11,393,340 | 1.41% |
| Archon Capital Management LLC | 1,361,769 | $5,719,430 | 1.28% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 2,947,329 | $12,378,782 | 0.80% |
| BARD ASSOCIATES INC | 291,297 | $1,223,448 | 0.50% |
| Portolan Capital Management | 1,043,546 | $4,382,893 | 0.42% |
| HEARTLAND ADVISORS INC | 1,200,000 | $5,040,000 | 0.31% |
| EAM Investors, LLC | 345,546 | $1,451,293 | 0.28% |